|
MechanismMYD88 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Not yet recruitingNot ApplicableIIT A Study on the Safety, Tolerability, and Preliminary Efficacy of CREPT-618 in Patients with Metabolic Dysfunction-Associated Steatohepatitis
/ Enrolling by invitationNot ApplicableIIT Impact of an Artificial Intelligence-Based Management Model on Psychological and Behavioral Outcomes in Breast Cancer Patients Undergoing Home CDK4/6 Inhibitor Therapy: A Multicenter Randomized Controlled Trial
This version uses full terminology and flows well for a research proposal or paper.
Primary Objective: To compare the intervention effects of an "AI-based management model," a "customized active follow-up model," and a "conventional patient education and follow-up model" on anxiety and depression in patients.
Secondary Objectives: To evaluate the impact of these models on patients' quality of life (QoL), patient-reported adverse events, medication adherence, serological markers, progression-free survival (PFS), and overall survival (OS).
Clinical Observation on the Treatment of Acute Pharyngitis, Tonsillitis, Acute Exacerbation of Chronic Pharyngitis and Other Upper Respiratory Tract Infections Causing Throat Pain and Other Discomforts with Diquichloramine Lozenges: A Randomized Controlled Study
100 Clinical Results associated with Tianjin Fifth Central Hospital
0 Patents (Medical) associated with Tianjin Fifth Central Hospital
100 Deals associated with Tianjin Fifth Central Hospital
100 Translational Medicine associated with Tianjin Fifth Central Hospital